VVUS

VIVUS, Inc. News Headlines

$2.29
*  
0.02
0.87%
Get VVUS Alerts
*Delayed - data as of Jul. 7, 2015  -  Find a broker to begin trading VVUS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By



Alibaba: An Opportunity Or The Opportunity
9/19/2014 12:40:00 AM - Seeking Alpha




Today's Market: Stocks Moving On News, Fed Rally Continues
9/18/2014 10:11:00 AM - Seeking Alpha








Orexigen Falls After Approval - Why?
9/15/2014 2:25:00 PM - Seeking Alpha








Belviq Sales See Holiday Dip - Still On Track
9/12/2014 5:17:00 PM - Seeking Alpha






Orexigen's Contrave Approved: What It Means To Arena
9/11/2014 10:02:00 AM - Seeking Alpha


FDA Approves Orexigen's Contrave For Obesity Treatment
9/11/2014 9:22:00 AM - Seeking Alpha






Belviq Sales Crack Critical Level
8/29/2014 4:46:00 PM - Seeking Alpha




Vivus Acquires Patent Rights To Qsymia Ingredient
8/25/2014 1:38:00 PM - Seeking Alpha


Advertising And The Belviq Re-Launch
8/25/2014 1:29:00 PM - Seeking Alpha


Belviq Sales Rise 2%
8/25/2014 9:57:00 AM - Seeking Alpha




Arena And VIVUS: A Case Study In Small-Cap Pharma
8/18/2014 7:53:00 AM - Seeking Alpha